4-(2-FLUORO-BENZYLOXY)-PHENYLAMINE
|
- $199 - $777.32
- Product name: 4-(2-FLUORO-BENZYLOXY)-PHENYLAMINE
- CAS: 57181-83-6
- MF: C13H12FNO
- MW: 217.24
- EINECS:
- MDL Number:MFCD08146647
- Synonyms:AKOS BC-2579;4-(2-FLUORO-BENZYLOXY)-PHENYLAMINE;ASISCHEM D19383;Benzenamine, 4-[(2-fluorophenyl)methoxy]-;4-((2-Fluorobenzyl)oxy)aniline;4-[(2-Fluorophenyl)methoxy]benzenamine
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number5846AE
- Product description4-(2-Fluoro-benzyloxy)-phenylamine
- Packaging500mg
- Price$318
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0107142
- Product description4-[(2-FLUOROPHENYL)METHOXY]ANILINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12059812
- Product description4-((2-Fluorobenzyl)oxy)aniline 97%
- Packaging5g
- Price$573
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number020015
- Product description4-(2-Fluoro-benzyloxy)-phenylamine
- Packaging500mg
- Price$199
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 5846AE | 4-(2-Fluoro-benzyloxy)-phenylamine | 500mg | $318 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | HCH0107142 | 4-[(2-FLUOROPHENYL)METHOXY]ANILINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
| Crysdot | CD12059812 | 4-((2-Fluorobenzyl)oxy)aniline 97% | 5g | $573 | 2021-12-16 | Buy |
| Matrix Scientific | 020015 | 4-(2-Fluoro-benzyloxy)-phenylamine | 500mg | $199 | 2021-12-16 | Buy |
Properties
Boiling point :357.7±22.0 °C(Predicted)
Density :1.202±0.06 g/cm3(Predicted)
pka :5.02±0.10(Predicted)
Density :1.202±0.06 g/cm3(Predicted)
pka :5.02±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|